Publications
Tarasco E, Bütikofer L, Friedman KD, George JN, Hrachovinoca I, Knöbl PN, Matsumoto M, von Krogh AS, Aebi-Huber I, Gorska-Kosicka M, Jaloviec KA, Largiadèr CR, Prohanszka Z, Sinkovits G, Windyga J, Lämmle B, Kremer Hovinga JA.
Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura
Blood 2021; doi: 10.1182/blood.2020009801.
Kremer Hovinga JA, Braschler TR, Buchkremer F, Farese S, Hengartner H, Lovey PY, Largiadèr CR, Mansouri Taleghani B, Tarasco E.
Insights from the Hereditary Thrombotic Thrombocytopenic Purpura Registry: Discussion of Key Findings Based on Individual Cases from Switzerland
Haemostaseologie.2020; doi: 10.1055/a-1282-2264
Wyatt KD, Kohorst MA, Coon LM, Hurley RM, van Dorland HA, Arndt CAS
Hereditary Thrombotic Thrombocytopenic Purpura in a 9-Month Old: Diagnosing and Managing an Ultra-rare Disorder
J Pediatr Hematol Oncol. 2020; doi: 10.1097/MPH.0000000000001830
Borogovac A, Tarasco E, Kremer Hovinga JA, George JN
Hypertension in patients with hereditary thrombotic thrombocytopenic purpura.
eJHaem. 2020;DOI:10.1002/jha2.29
Tarasco E, Aebi-Huber I, Kremer Hovinga JA
The Hereditary TTP Registry: who we are, what we do, why you should join us
Leading opinions in Hämotologie and Onkologie
Tarasco E, Aebi-Huber I, Kremer Hovinga JA
Die erbliche Form der thrombotisch trombozytopenischen Purpura (TTP) - selten, aber bei Schwangerschaftskomplikationen zu bedenken!
Kremer Hovinga JA, George JN
Hereditary Thrombotic Thrombocytopenic Purpura.
N Engl J Med. 2019;381(17):1653-1662
van Dorland HA, Taleghani MM, Sakai K, Friedman KD, George JN, Hrachovinova I, Knöbl PN, von Krogh AS, Schneppenheim R, Aebi-Huber I, Bütikofer L, Largiadèr CR, Cermakova Z, Kokame K, Miyata T, Yagi H, Terrell DR, Vesely SK, Matsumoto M, Lämmle B, Fujimura Y, Kremer Hovinga JA; Hereditary TTP Registry
The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017.
Haematologica. 2019;104(10):2107-2115
Kremer Hovinga JA, Heeb SR, Skowronska M, Schaller M
Pathophysiology of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
J Thromb Haemost. 2018;16(4):618-629
Scully M, Knöbl P, Kentouche K, Rice L, Windyga J, Schneppenheim R, Kremer Hovinga JA, Kajiwara M, Fujimura Y, Maggiore C, Doralt J, Hibbard C, Martell L, Ewenstein B
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.
Blood. 2017;130(19): 2055-2063
Kremer Hovinga JA, Coppo P, Lämmle B, Moake JL, Miyata T, Vanhoorelbeke K
Thrombotic thrombocytopenic purpura.
Nat Rev Dis Primers. 2017;3:17020
Von Krogh A-S, Quist-Paulsen P, Waage A, Langseth ØO, Thorstensen K, Brudevold R, Tjønnfjord GE, Largiadèr CR, Lämmle B, Kremer Hovinga JA
High prevalence of hereditary thrombotic thrombocytopenic purpura in Central Norway: from clinical observation to evidence.
J Thromb Haemost. 2016;14(1):73-82
Von Krogh A-S, Kremer Hovinga JA, Romundstad PR, Roten LT, Lämmle B, Waage A, Quist-Paulsen P
ADAMTS13 gene variants and function in women with preeclampsia: a population-based nested case-control study from the HUNT study.
Von Auer C, von Krogh A-S, Kremer Hovinga JA , Lämmle B
Current insights into thrombotic microangiopathies: Thrombotic thrombocytopenic purpura and pregnancy.
Thromb Res. 2015;135(Suppl. 1):S30–S33
Raval JS, Padmanabhan A, Kremer Hovinga JA, Kiss JE
Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpura.
Falter T, Kremer Hovinga JA, Lackner K, Füllemann H-G, Lämmle B, Scharrer I
Late onset and pregnancy-induced congenital thrombotic thrombocytopenic purpura.
Haemostaseologie. 2014;34:244–24
Von Krogh A-S, Kremer Hovinga JA, Tjønnfjord GE, Ringen IM, Lämmle B, Waage A, Quist-Paulsen P
The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications.
Thromb Haemost. 2014;111:1180–1183
Knöbl P
Inherited and acquired thrombotic thrombocytopenic purpura (TTP) in adults.
Semin Thromb Hemost. 2014;40:493-502
Bennett M, Chubar Y, Gavish I, Aviv A, Stemer G, Chap-Marshak D
Experiences in a Family With the Upshaw-Schulman Syndrome Over a 44-Year Period.
Clin Appl Thromb Hemost. 2014;20:296-303
Rank CU, Kremer Hovinga JA, Taleghani MM, Lämmle B, Gøtze JP, Nielsen OJ
Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene.
Eur J Haematol. 2014;92:168-71
Knöbl PN
Treatment of thrombotic microangiopathy with a focus on new treatment options.
Haemostaseologie. 2013;33:149-59
Kentouche K, Voigt A, Schleussner E, Schneppenheim R, Budde U, Beck JF, Stefanska-Windyga E, Windyga J
Pregnancy in Upshaw-Schulman syndrome.
Haemostaseologie. 2013;29;33:144-8
Mansouri Taleghani M, von Krogh A-S, Fujimura Y, George JN, Hrachovinova I, Knöbl PN, Quist-Paulsen P, Schneppenheim R, Lämmle B, Kremer Hovinga JA
Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman syndrome) and the hereditary TTP registry.
Haemostaseologie. 2013;33:138–143
Deal T, Kremer Hovinga JA, Marques MB, Adamski J
Novel ADAMTS13 Mutations in an Obstetric Patient with Upshaw-Schulman Syndrome.
Kremer Hovinga JA, Lämmle B
ADAMTS13: Its role in pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura.